Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | RARB | P10826 | 6/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | RARA | P10276 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9635304 | 0.94 | RARB (0.59) | ALDH1A1KMT2ARARBMEN1MAPT | |
| SCHEMBL49090 | 0.83 | ALDH1A1 (0.61) | ALDH1A1KMT2ARARBTP53TSHR | |
| Benzoic Acid SCHEMBL31606729 | 0.82 | TP53 (0.56) | ALDH1A1TP53MAPTSMN1; SMN2USP2 | |
| SCHEMBL10455113 | 0.82 | KMT2A (0.42) | ALDH1A1KMT2AMAPTSMN1; SMN2POLB | |
| SCHEMBL6015468 | 0.82 | ALDH1A1 (0.38) | ALDH1A1KMT2AMEN1MAPTSMN1; SMN2 | |
| SCHEMBL28170706 | 0.81 | ALDH1A1 (0.59) | ALDH1A1KMT2ARARBTP53TSHR | |
| SCHEMBL11300567 | 0.80 | KMT2A (0.38) | ALDH1A1KMT2ASMN1; SMN2KDM4EPOLB | |
| SCHEMBL14495580 | 0.80 | POLB (0.52) | ALDH1A1KMT2ATSHRPOLBGAA | |
| SCHEMBL2000488 | 0.80 | RARB (0.56) | ALDH1A1KMT2ARARBTP53TSHR | |
| Terephthalic Acid SCHEMBL1929898 | 0.79 | TSHR (0.71) | ALDH1A1KMT2ATP53TSHRSRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025041533-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND FILM-FORMING COMPOSITION | JSR株式会社 | 2025-02-27 | — | — | WO | disclosed |
| CN-110684350-A | Electrical equipment shell material for hydrogen explosion-proof environment | 张家港氢芯电气系统科技有限公司 | 2020-01-14 | — | — | CN | disclosed |
| EP-1953239-B1 | METHOD FOR DETERMINATION OF ALLERGEN IN ENVIRONMENT AND KIT FOR SIMPLE QUANTIFICATION OF ALLERGEN | JAPAN SCIENCE & TECH AGENCY (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-8012708-B2 | Method for determination of allergen in environment and kit for simple quantification of allergen | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20090215814-A1 | Method of inhibiting neurotrophin-receptor binding | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2009-08-27 | — | — | US | disclosed |
| US-20090203058-A1 | Method for determination of allergen in environment and kit for simple quantification of allergen | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-08-13 | — | — | US | disclosed |
| US-7541368-B2 | 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-{3-[1-(1-methyl-cyclopropanecarbonyl)-piperidin-4-ylmethyl]-phenyl}-urea; use in the treatment of disease states capable of being modulated by the inhibition of p38 kinase and tumor necrosis factor (TNF) | AVENTIS PHARMACEUTICALS INC. (US) | 2009-06-02 | — | — | US | disclosed |
| WO-2008120811-A1 | ORGANIC - INORGANIC HYBRID COMPOSITION | FUJIFILM CORPORATION (JP) | 2008-10-09 | — | — | WO | disclosed |
| EP-1953239-A1 | METHOD FOR DETERMINATION OF ALLERGEN IN ENVIRONMENT AND KIT FOR SIMPLE QUANTIFICATION OF ALLERGEN | Japan Science and Technology Agency (JP) | 2008-08-06 | — | — | EP | disclosed |
| US-20080050764-A1 | Method and Apparatus for Measuring Enviromental Allergen | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-02-28 | — | — | US | disclosed |
| WO-2008014221-A2 | BRIDGED CARBAMATE MACROLIDES | ENANTA PHARMACEUTICALS, INC. (US) | 2008-01-31 | — | — | WO | disclosed |
| EP-1622610-B1 | 1-(2H-PYRAZOL-3-YL)-3-{4-[1-(BENZOYL)-PIPERIDIN-4-YLMETHYL]-PHENYL}-UREA DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF P38 KINASE AND/OR TNF INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS | AVENTIS PHARMA INC (US) | 2006-12-20 | — | — | EP | disclosed |
| EP-1712637-A1 | METHOD AND APPARATUS FOR MEASURING ENVIRONMENTAL ALLERGEN | Japan Science and Technology Agency (JP) | 2006-10-18 | — | — | EP | disclosed |
| US-20060063796-A1 | Pyrazoles as inhibitors of tumor necrosis factor | AVENTIS PHARMACEUTICALS INC. (US) | 2006-03-23 | — | — | US | disclosed |
| EP-1622610-A1 | 1-(2H-PYRAZOL-3-YL)-3- 4-[1-(BENZOYL)-PIPERIDIN-4-YLMETHYL]-PHENYL -UREA DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF P38 KINASE AND/OR TNF INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS | Aventis Pharmaceuticals Inc. (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004100946-A1 | 1- (2H-PYRAZOL -3-YL) -3YL) {4-`1- (BENZOYL) -PIPERIDIN-4-YLMETHYL!-PHENYL}-UREA DERIVATIVES AND RELATED COMPOUNDS AS INHBITORS OF P38 KINASE AND/OR TNF INHIBITORS FOR THE TREATMENT OF IMFLAMMATIONS | AVENTIS PHARMACEUTICALS INC. (US) | 2004-11-25 | — | — | WO | disclosed |
| EP-0283326-B1 | LIQUID CRYSTAL COMPOUNDS WITH 4-(OPTICALLY ACTIVE ALKYL)-3-CYANOPHENYL GROUPS | Chisso Corporation (JP) | 1992-06-24 | — | — | EP | disclosed |
| US-4913838-A | LARGE SPONTANEOUS POLARIZATION VALUE | CHISSO CORPORATION (JP) | 1990-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215814-A1 | Method of inhibiting neurotrophin-receptor binding | NGF, NTRK2, BDNF | ALDH1A1 2096/4885KMT2A 3466/4885RARB 2710/4885 |
| US-20060063796-A1 | Pyrazoles as inhibitors of tumor necrosis factor | TNF, LITAF, MAPK1 | ALDH1A1 1448/4885KMT2A 4746/4885RARB 2930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.